General Pharmaceutical Council
Regulator meets all scrutiny standards for third year in a row
The General Pharmaceutical Council (GPhC) has met all the Professional Standards Authority’s (PSA) Standards of Good Regulation for the third consecutive year.
The PSA oversees all nine health and social care regulators, and its for 2017/2018 covered areas including council papers, fitness-to-practise reports, audit committee reports and business plan monitoring reports.
The PSA report highlighted ways in which the GPhC is meeting the PSA’s standards for good regulation, including by widely consulting with stakeholders in developing guidance and standards and by ensuring that education and training for pharmacies, pharmacy technicians and the unregistered pharmacy team were appropriate and relevant.
Duncan Rudkin, chief executive of the GPhC, said recognition by the PSA “gives important assurance to patients and the public that we are working effectively to make sure they receive safe and effective pharmacy services”.
Citation: The Salvadore DOI: 10.1211/PJ.2018.20205521
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.£60.00
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.£38.00